BioCentury
ARTICLE | Financial News

GlobeImmune raises $34.3 million

September 15, 2005 1:30 AM UTC

Cancer and infectious disease company GlobeImmune (Denver, Colo.) raised $34.3 million in a series B round led by Lilly Ventures. New investors Medica Holdings; Adams Street Partners; Biogen Idec (BII...